English
简体中文
Total: £ 56.28
2024-10-17 | Pages: 97 | Tables: 206
Human varicella-zoster immune globulin is a solution of antibodies used for post exposure prophylaxis of varicella infections in high risk populations, as well as to reduce the severity of infections. The global market for Human Varicella-Zoster Immu...
2024-10-17 | Pages: 147 | Tables: 265
Human prothrombin complex concentrate, also known as factor IX complex, is a plasma-derived coagulation factor extract, which was originally used to treat factor IX deficiency, because PCC also contains coagulation factors II, VII, and X, so PCCs are...
2024-10-17 | Pages: 98 | Tables: 217
To prevent sensitisation in cases where the mother’s immune system may attack the baby’s red blood cells during pregnancy, thus avoiding harm to the foetus. The global market for Anti-D Immunoglobulin was estimated to be worth US$ million in 2023 and...
2024-10-17 | Pages: 133 | Tables: 254
Urogonadotropin for injection for female infertility caused by hypogonadotropic or normogonadotropic ovarian insufficiency The global market for Urotropin for Injection was estimated to be worth US$ million in 2023 and is forecast to a readjusted siz...
2024-10-17 | Pages: 146 | Tables: 249
Complementary therapy for prevention and treatment of hemophilia A acquired coagulation factor Ⅷ deficiency and von Willebrand's disease The global market for Human Factor VIII Concentrate was estimated to be worth US$ 185 million in 2023 and is fore...
2024-10-17 | Pages: 121 | Tables: 228
Thrombin Ⅲ (antithrombin Ⅲ, AT-Ⅲ) is a multifunctional serine protease inhibitory protein in human plasma and an important anticoagulant factor in blood, which plays an important role in the physiological coagulation mechanism. The global market for ...
2024-10-17 | Pages: 129 | Tables: 241
Vaccines administered nasally The global market for Intranasal Vaccine was estimated to be worth US$ 565 million in 2023 and is forecast to a readjusted size of US$ 797.4 million by 2030 with a CAGR of 5.0% during the forecast period 2024-2030 The gl...
2024-10-17 | Pages: 96 | Tables: 203
Hib vaccine is a vaccine to prevent invasive diseases caused by Hib, such as meningitis, pneumonia, epiglottitis, sepsis, cellulitis, pericarditis, myelitis, etc. The global market for Hib Vaccine was estimated to be worth US$ 1154 million in 2023 an...
2024-10-17 | Pages: 126 | Tables: 237
In the process of root canal treatment, after the root canal is formed, relevant drugs are filled in the root canal to completely remove the pathogenic microorganisms in the infected root canal. The global market for Root Canal Temporary Sealing Drug...
2024-10-17 | Pages: 101 | Tables: 198
Messenger RNA (mRNA) is a single-stranded long ribonucleic acid that can transmit genetic information in DNA and synthesize proteins through translation. After mRNA enters the body, specific proteins can be expressed by autologous cells, avoiding the...
2024-10-17 | Pages: 81 | Tables: 188
C5 inhibitors are a class of drugs that specifically target the protein C5 in the complement system. The complement system is part of the immune system and plays a vital role in immune defense and inflammation. C5 is one of the key components of the ...
2024-10-17 | Pages: 147 | Tables: 264
Drugs made by genetically modified means are also called "biological drugs" The global market for Genetically Modified Drug was estimated to be worth US$ 2314 million in 2023 and is forecast to a readjusted size of US$ 3481 million by 2030 with a CAG...
2024-10-17 | Pages: 126 | Tables: 239
Epidemic Japanese encephalitis (hereinafter referred to as "JE") is an acute infectious disease of the central nervous system caused by the Japanese encephalitis virus, with inflammation of the brain parenchyma as the main lesion. The global market f...
2024-10-17 | Pages: 104 | Tables: 211
Inactivated vaccines are safer The global market for JE Inactivated Vaccine was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030. The global ph...
2024-10-17 | Pages: 105 | Tables: 209
Influenza virus split vaccine is made by inoculating chicken embryos with influenza virus strains recommended by the World Health Organization (WHO) and approved by the national drug administration department, cultured, harvested virus liquid, virus ...
